Phase 2 Study: OBI-833/OBI-821 Maintenance for Globo H+ Advanced Biliary Tract Cancer After Gemcitabine/Cisplatin
Clinical trial NCT06490198 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06490198
- Sponsor
- Chang Gung Memorial Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-31
- Primary completion
- 2026-07-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.